Literature DB >> 29248622

Partial enteral nutrition increases intestinal sIgA levels in mice undergoing parenteral nutrition in a dose-dependent manner.

Haifeng Sun1, Jingcheng Bi2, Qiucheng Lei3, Xiao Wan4, Tingting Jiang5, Chao Wu6, Xinying Wang7.   

Abstract

BACKGROUND AND AIMS: Partial enteral nutrition (PEN) protects parenteral nutrition (PN) induced gut mucosal immunity impairment. However, the gastrointestinal function of most patients with PN is too poor to tolerate full dosage of PEN and no guidelines recommend PEN dose. We aimed to identify an optimal PEN dose and to understand the protective mechanism.
METHODS: Mice were assigned to groups with total parenteral nutrition (TPN), total enteral nutrition (TEN), or various degrees of PEN with PN. Additionally, AS1517499 was used to inhibit STAT6. Five days after treatment, secretory immunoglobulin A (sIgA) levels of luminal washing fluid and JAK1-STAT6 signalling in ileum tissue of different groups were assessed.
RESULTS: We found that TPN lowered luminal sIgA and down-regulated pIgR, phosphorylated JAK1 and STAT6, IL-4 and IL-13 as well relative to TEN. Moreover, 40% EN were lowest dose that reversed these detrimental consequences of PN to an equivalent level as TEN. The rescue of pIgR and luminal sIgA expression was decreased when the JAK1-STAT6 pathway was inhibited.
CONCLUSION: We conclude that 40% EN is the optimal PEN dose that reverses PN-induced impairment of gut mucosal immunity. Additionally, we hypothesise that this benefit involves activation of the JAK1-STAT6 pathway.
Copyright © 2017 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gut barrier; Mucosal immunity; Parenteral nutrition; Partial enteral nutrition; Secretory immunoglobulin A

Mesh:

Substances:

Year:  2017        PMID: 29248622     DOI: 10.1016/j.ijsu.2017.12.011

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  7 in total

1.  Effect of Peptides from Alaska Pollock on Intestinal Mucosal Immunity Function and Purification of Active Fragments.

Authors:  Qiqi Li; Shikai Wang; Supanooch Poungchawanwong; Hu Hou
Journal:  Nutrients       Date:  2019-10-18       Impact factor: 5.717

2.  EpCAM Is Essential to Maintaining the Immune Homeostasis of Intestines via Keeping the Expression of pIgR in the Intestinal Epithelium of Mice.

Authors:  Zili Lei; Wanwan Liu; Ya Nie; Yanhong Yang; Guibin Chen; Li Huang; Huijuan Wu; Yuting Lei; Lei Chen; Qing Hu; Hedong Rong; Siping Yu; Qi Song; Fengxue Tong; Jiao Guo
Journal:  Front Immunol       Date:  2022-04-13       Impact factor: 8.786

3.  Lactobacillus plantarum BSGP201683 Improves the Intestinal Barrier of Giant Panda Microbiota-Associated Mouse Infected by Enterotoxigenic Escherichia coli K88.

Authors:  Yi Zhou; Xueqin Ni; Ling Duan; Lili Niu; Qian Liu; Yan Zeng; Qiang Wang; Jie Wang; Abdul Khalique; Kangcheng Pan; Bo Jing; Dong Zeng
Journal:  Probiotics Antimicrob Proteins       Date:  2020-11-14       Impact factor: 4.609

Review 4.  Targeting JAK/STAT signaling pathways in treatment of inflammatory bowel disease.

Authors:  Liang Wang; Yan Hu; Baohui Song; Yongjian Xiong; Jingyu Wang; Dapeng Chen
Journal:  Inflamm Res       Date:  2021-07-01       Impact factor: 4.575

5.  Dietary Soy Protein Isolate Attenuates Intestinal Immunoglobulin and Mucin Expression in Young Mice Compared with Casein.

Authors:  Bin Zeng; Dongyang Wang; Hailong Wang; Ting Chen; Junyi Luo; Qianyun Xi; Jiajie Sun; Yongliang Zhang
Journal:  Nutrients       Date:  2020-09-08       Impact factor: 5.717

Review 6.  How the Covid-19 epidemic is challenging our practice in clinical nutrition-feedback from the field.

Authors:  Ronan Thibault; Moïse Coëffier; Francisca Joly; Julien Bohé; Stéphane M Schneider; Pierre Déchelotte
Journal:  Eur J Clin Nutr       Date:  2020-09-16       Impact factor: 4.016

7.  Short-term clinical outcomes of enteral nutrition versus parenteral nutrition after surgery for pancreatic cancer: a meta-analysis.

Authors:  Yi-Kun Kang; Li Dong; Yang Ge; Guang-Yu An
Journal:  Transl Cancer Res       Date:  2019-08       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.